首页 | 本学科首页   官方微博 | 高级检索  
检索        

沐舒坦在慢性阻塞性肺疾病急性期合并呼吸衰竭患者的临床疗效观察
引用本文:崔红,玛依拉.阿不都克力木.沐舒坦在慢性阻塞性肺疾病急性期合并呼吸衰竭患者的临床疗效观察[J].现代预防医学,2011,38(17):3574-3575,3578.
作者姓名:崔红  玛依拉.阿不都克力木
作者单位:新疆医科大学第六附属医院急诊科,乌鲁木齐,830002
摘    要:目的]探讨氧化驱动雾化吸入沐舒坦治疗慢性阻塞性肺疾病急性期合并呼吸衰竭的临床疗效。方法]选择110例慢性阻塞性肺疾病急性期合并呼吸衰竭患者,随机分为两组,在综合治疗基础上,治疗组采用氧化驱动雾化吸入沐舒坦治疗,对照组采用氧化驱动雾化吸入生理盐水20ml+糜蛋白酶2000u+地塞米松5mg治疗,比较两组治疗临床疗效。结果]两组患者经治72h后PaO2、PaCO2差异均有统计学意义(P﹤0.05)。治疗组57例,治疗结束后显效15例(26.32%),有效28例(49.12%),无效14例(24.56%);对照组53例,治疗结束后显效8例(15.09%),有效20例(37.74%),无效25例(47.17%)。两组疗效比较组间资料采用卡方检验,χ2=6.4294,P=0.0402﹤0.05。结论]在综合治疗基础上,采用氧化驱动雾化吸入沐舒坦针对慢性阻塞性肺疾病急性加重期合并呼吸衰竭是一种有效的治疗方法,值得广泛应用。

关 键 词:沐舒坦  慢性阻塞性肺疾病急性期  呼吸衰竭

CLINICAL OBSERVATION OF MUCOSOLVAN IN THE ACUTE STAGE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH RESPIRATORY FAILURE
CUI Hong,Mayila· Abu-doukelimu.CLINICAL OBSERVATION OF MUCOSOLVAN IN THE ACUTE STAGE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH RESPIRATORY FAILURE[J].Modern Preventive Medicine,2011,38(17):3574-3575,3578.
Authors:CUI Hong  Mayila· Abu-doukelimu
Institution:CUI Hong,Mayila·Abudoukelimu.(Department of Emergency,Sixth Affiliated Hospital,Xinjiang Medical University,Urumqi 830002,China)
Abstract:Objective]To discuss the clinical efficacy of oxidation-driven inhalation of ambroxol treatment of chronic obstructive pulmonary disease,acute respiratory failure.Methods]Selected 110 cases of chronic obstructive pulmonary disease in patients with acute respiratory failure were randomly divided into two groups based on the combined therapy,the treatment group driven by oxidation Mucosolvan inhalation treatment,the control group inhaled normal saline by oxidation 20 ml + drive Chymotrypsin 2 000 u + 5 mg d...
Keywords:Mucosolvan  Acute stage of chronic obstructive pulmonary disease  Respiratory failure  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号